Asian Journal of Research and Reports in Ophthalmology https://journalajrrop.com/index.php/AJRROP <p style="text-align: justify;"><strong>Asian Journal of Research and Reports in Ophthalmology</strong>&nbsp;aims to publish&nbsp;high-quality&nbsp;papers (<a href="/index.php/AJRROP/general-guideline-for-authors">Click here for Types of paper</a>) in all aspects of&nbsp;‘Ophthalmology’. This journal facilitates the research and wishes to publish papers as long as they are technically correct, scientifically motivated. The journal also encourages the submission of useful reports of negative results. This is a quality controlled,&nbsp;OPEN&nbsp;peer-reviewed, open access INTERNATIONAL journal.</p> <p style="text-align: justify;">&nbsp;</p> Asian Journal of Research and Reports in Ophthalmology en-US Asian Journal of Research and Reports in Ophthalmology Treating Submacular Hemorrhage with Intravitreal tPA Injection and Pneumatic Displacement https://journalajrrop.com/index.php/AJRROP/article/view/30141 <p><strong>Background</strong><strong>:</strong> This report describes the clinical outcome in an adult male with spontaneous submacular hemorrhage who underwent successful intravitreal tPA injection and pneumatic displacement.</p> <p><strong>Case Presentation: </strong>A 30 yr old male patient presented with complaints of sudden painless diminution of vision in left eye since one day. The vision on presentation was Hand Movements +. Fundus showed a submacular hemorrhage with breakthrough vitreous hemorrhage. Injection tPA (25μg in 0.05 ml) and pure sulfur hexafluoride (SF6, 0.3 ml) was injected into the vitreous cavity. After surgery the patient was instructed to maintain a prone position. This was followed by a vitrectomy after 2 weeks. Postoperatively, patient had significantly improved having an unaided vision of 6/9P in the left eye which improved to 6/6 on correction.</p> <p><strong>Conclusion:</strong> Intravitreal tPA and pneumatic displacement using pure SF6 is an effective treatment for submacular hemorrhage.</p> Rakshan Reyaz Syed Sadaf Altaf Sabia Rashid Asif Amin Vakil ##submission.copyrightStatement## 2021-12-29 2021-12-29 22 26 Conjunctival Pyogenic Granuloma Associated with Untreated Eye Stye: A Case Report https://journalajrrop.com/index.php/AJRROP/article/view/30142 <p><strong>Introduction: </strong>To report a case of conjunctival pyogenic granuloma (PG) associated with untreated eye stye that was successfully treated with corticosteroids.</p> <p><strong>Presentation of Case:</strong>&nbsp; 69 years old male was presented with redness and foreign body sensation (FBS) on his left eye (LE) that had lasted for a week. He has no history of eye trauma but he had eye stye one month earlier, which was left untreated and unintentionally ruptured. Visual acuity (VA) of 6/7,5 was measured on LE with normal intraocular pressure (IOP). Anterior segment evaluation found conjunctival vascular injection (CVI) on the bulbar conjunctiva and sessile mass of granulation tissue on the superior tarsal conjunctiva. He was treated by oral and topical corticosteroids with tapering dose. After five weeks of treatment, significant improvements were observed in the eye symptoms together with decreasing granuloma size, i.e., smaller and thinner without recurrence.</p> <p><strong>Discussion:</strong> PG is diagnosed through clinical presentations supported by the patient’s historical predisposing factors. Corticosteroid therapy can effectively reduce the size of PG with relatively simple procedure. However, it requires close monitoring of the IOP and tapering dose to anticipate the potential side effects. Surgical excision and histological evaluation are considered if the lesions cannot be resolved by corticosteroid therapy.</p> <p><strong>Conclusion:</strong> Combined oral and topical corticosteroids therapy is recommended as an initial treatment for PG patients.</p> Anak Agung Putri Satwika I Gusti Ayu Made Juliari ##submission.copyrightStatement## 2021-12-29 2021-12-29 27 32 Spectrum of Ophthalmic Findings in Recurrent Pituitary Adenoma Patients: Case Series https://journalajrrop.com/index.php/AJRROP/article/view/30143 <p>Pituitary adenomas are relatively common intracranial lesions. Decrease of visual acuity, visual field deficit, and headaches are the neurological signs associated with it commonly seen in ophthalmology. We report 3 cases of recurrent pituitary macroadenoma with different clinical presentations. This case series emphasizes the importance of evaluation and documentation of ophthalmic findings and visual fields in patients with pituitary adenoma pre and post operatively, to estimate the extent of optic pathway involvement.</p> Yogya Reddy Farraz Hussain Abha Shah ##submission.copyrightStatement## 2021-12-29 2021-12-29 33 38 Uveitis: Classification, Diagnosis, and Treatment https://journalajrrop.com/index.php/AJRROP/article/view/30139 <p><strong>Background:</strong> Uveitis is a common disease that mainly affects young people. This leads to a significant loss of material. Acute anterior uveitis is the most common form and is most often associated with spondyloarthritis, in which uveitis may be the first manifestation of the disease. Specific patterns of uveitis are generally associated with systemic disease. Therefore, close collaboration between ophthalmologists and orthopedic surgeons avoids unnecessary diagnostic tests and is essential for accurate diagnosis and treatment of these patients. Acute anterior uveitis is often better diagnosed than other forms of uveitis. However, it can cause paralysis when inflammation is common. Small prospective studies with sulfasalazine have shown a decrease in growth. In some forms of uveitis, diagnosis is difficult and systemic corticosteroids and/or suppression of the immune system may require medication. Infliximab is a promising treatment for select patients.</p> <p><strong>Conclusion:</strong> Uveitis in childhood is a serious disease associated with vision-threatening problems. Uveitis associated with juvenile rheumatoid arthritis remains the leading cause of eye disease in patients with childhood uveitis.</p> Omar Elsaka ##submission.copyrightStatement## 2021-12-13 2021-12-13 1 9 Glaucoma: Diagnosis and Treatment https://journalajrrop.com/index.php/AJRROP/article/view/30140 <p><strong>Background:</strong> In the United States, glaucoma is the second most prevalent cause of official blindness. Open-angle glaucoma is an asymptomatic, progressive optic neuropathy marked by increased optic disc cupping and vision loss. Patients over the age of 40, whites over the age of 65, and those with a family history of glaucoma or a personal history of diabetes or acute myopia are all at high risk for open glaucoma. Although high intraocular pressure is a major and variable risk factor for open glaucoma, it is not a diagnostic factor. Normal intraocular pressure is present in some glaucoma patients (i.e., normal pressure glaucoma), and most patients with high intraocular pressure do not have glaucoma (i.e., suspected glaucoma). Physicians who treat glaucoma patients do not recommend using a conventional measurement of intraocular pressure. Adults with open-angle glaucoma are commonly diagnosed during routine eye exams. Ophthalmologists and ophthalmologists collaborate on the ultimate diagnosis and therapy. The basic foundation for the diagnosis and therapy of glaucoma is the systemic area of visual acuity (perimetry). Beta-blockers are commonly given as eye drops in the form of intravenous or prostaglandin analog drops, and they are frequently the first treatment to lower intraocular pressure. Laser therapy and surgery are often reserved for individuals who have failed to respond to other treatments. Open-angle glaucoma can cause irreparable visual loss if not treated.</p> <p><strong>Conclusion:</strong> Glaucoma is a disease that poses difficulty to many people. Many kinds of glaucoma have core pathogenesis that we don't fully understand.</p> Omar Elsaka ##submission.copyrightStatement## 2021-12-13 2021-12-13 10 21